Antibody responses of healthy neonates to two mixed regimens of hepatitis B vaccine

Pediatric Infectious Disease Journal

Volumn 18, Issue 9, 1999, Pages 840-842

  Seto, Dexter ^a   West, David J ^b   Gilliam, Rebecca R ^b   Ioli, Virginia A ^b   Ferrara, David K ^b   Rich, Beverly ^b  

^a KAPIOLANI MEDICAL CENTER FOR WOMEN AND CHILDREN   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Hepatitis B; Hepatitis B vaccine; Mixed vaccination regimens

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; ERYTHEMA; HEPATITIS B; HUMAN; INJECTION SITE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION; VIRUS HEPATITIS;

HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; VACCINES, SYNTHETIC;

EID: 0032868852     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199909000-00025     Document Type: Article

References (6)

1. Centers for Disease Control. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee. MMWR 1991;40(RR-13):1-25.
2. Committee on Infectious Diseases, American Academy of Pediatrics. Universal hepatitis B immunization. Pediatrics 1992;37:585-601.
3. Prescribing information for RECOMBIVAX HB® [Hepatitis B vaccine (recombinant)], Merck, 7462214, issued, February, 1996.
4. Prescribing information for Engerix-B [Hepatitis B vaccine (recombinant)], SmithKline Beecham, EB:L15B.
5. Sitrin RD, Wampler E, Ellis RW. Survey of licensed hepatitis B vaccines and their production processes. In: Ellis RW, ed. Hepatitis B vaccine in clinical practice. New York: Dekker, 1993:83-101.
6. COMVAX [Haemophilus b conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine], Merck, 9024701, issued December, 1996.